Viewing Study NCT01835860


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-03-06 @ 3:02 AM
Study NCT ID: NCT01835860
Status: COMPLETED
Last Update Posted: 2016-04-07
First Post: 2013-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Prostatic Artery Embolization for Benign Prostatic Hyperplasia
Sponsor: Saskatchewan Health Authority - Regina Area
Organization:

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2016-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate whether Prostatic Artery Embolization (PAE) might be an effective alternative treatment option for benign prostatic hyperplasia (BPH), in comparison to current gold standard surgical treatment- Transurethral Resection of Prostate (TURP).
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: